Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Clinical Investigators - Disqualification Proceedings
  • Print
  • Share
  • E-mail
  • FDA Home
  • Clinical Investigators - Disqualification Proceedings
-

Compliance and Enforcement

Regulatory Activities

Clinical Investigators - Disqualification Proceedings


Return to Introductory Page
Download Clinical Investigators - Disqualification Proceedings data in Microsoft Excel web format  Click on this link to download all data from the selected searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players .



Advanced Search

   No. of Records Found:  230
Name Center Status Date of status Date NIDPOE Issued Date NOOH Issued Link to NIDPOE Letter Link to NOOH Letter
Steele, Peter P., MD CDER Disqualified 04/02/1986
Rackley, Charles E., MD CDER Restrictions Removed 03/17/1986 08/26/1982
Klein, Donald F., MD CDER Not Disqualified – Adequate Assurances1 03/14/1986
Moskowitz, George, MD CDER Restrictions Removed 01/31/1986 05/20/1982
Baratta, Vincent J, MD CDER Disqualified 11/13/1985
Steen, Stephen N., MD Burea Not Disqualified – Adequate Assurances1 09/05/1985
Rowan, Noel M., MD CDER Disqualified 06/10/1985
Winchester, James F., MD CDER Restrictions Removed 05/24/1985 05/24/1982
Fogari, Robert, MD CDER Totally Restricted 04/24/1985
Weiss, Jerome, MD CDER Disqualified 12/31/1984
Guerin, Bernard K., MD CDER Disqualified 11/13/1984 07/02/1984
Lippmann, Maurice, MD Burea Reinstated – Adequate Assurances1 11/05/1984
Feurst, Samuel I., MD CDER Disqualified 10/02/1984 09/23/1983
Crane, Daniel L., MD CDER Disqualified 06/27/1984
Hotchkiss, Jr., Dwight J., MD CDER Disqualified 06/25/1984
Dressler, David M., MD CDER Disqualified 03/14/1984 02/07/1984
Shirley, Sheridan W., MD CDER Totally Restricted 01/30/1984
Carter, Thomas N., MD CDER Disqualified 11/22/1983 09/09/1983
John, Jr., J T., MD CDER Disqualified 11/04/1983
Wallens, William T., MD CDER Disqualified 08/22/1983
Bruschi, Walter C., MD CDER Totally Restricted 06/28/1983
Smith, Lyman, MD CDER Reinstated 06/08/1983
Hopkinson, III., John H., MD CDER Not Disqualified – Adequate Assurances 1 06/03/1983
Gamarra, Miguel H., MD CDER Disqualified 05/31/1983
Shroff, Phyllis F., MD CDER Totally Restricted 04/26/1983 07/31/1981
Mok, Martin S., MD Burea Not Disqualified – Adequate Assurances1 03/23/1983
Sanguilly, Manuel, MD CDER Disqualified 11/23/1982 04/02/1982
Garetz, Floyd K., MD CDER Disqualified 11/23/1982
Franklin, William C., MD CDER Disqualified 11/09/1982 10/20/1981 08/26/1982
Knapp, Richard B., MD CDER Disqualified 11/04/1982 03/12/1982
Aronow, Wilbert S., MD CDER Totally Restricted 10/28/1982
Young, Robert E., MD CDER Disqualified 10/15/1982
Roth, Stanley F., MD CDER Disqualified 08/03/1982 05/07/1982
Sherwin, Duane, MD CDER Disqualified 07/09/1982
Wong, David T., MD CDER Totally Restricted 07/09/1982 10/06/1980
Taber, David O., MD CDER Totally Restricted 06/17/1982 09/26/1980 02/09/1981
Straus, Marc J., MD CDER Disqualified 05/18/1982
Cataldo, Joseph R., MD CDER Totally Restricted 04/14/1982
Bazo, Albert J., MD CDER Restricted 11/04/1981 11/04/1981
Gelfand, Michael C., MD Burea Not Disqualified 09/11/1981
Kleber, Ronald, MD CDER Disqualified 08/06/1981 07/16/1980 12/04/1980
Ortiz, Julio A., MD CDER Disqualified 12/03/1980
Kline, Nathan S., MD CDER Disqualified 11/13/1980
Bowling, Chetwynd E., MD CDER Disqualified 11/13/1980
Novo, Felipe P., MD CDER Disqualified 11/04/1980
Ritter, Arnold, DO CDER Disqualified 02/28/1980
Levin, Harvey M., MD CDER Disqualified 02/01/1980
Smith, Ronald C., MD CDER Disqualified 08/01/1979
Scheiner, James J., MD CDER Disqualified 07/31/1979
Blunck, Jr., Carl E., MD CDER Disqualified 07/07/1979

Prev  |  Next  |  1  |  2  |  3  |  [4]  |  5  |  First  |  Last  |  All

1.Under regulations in effect until 1987, investigators who met the standard for disqualification (repeated or deliberate failure to comply with applicable requirements) could potentially avoid disqualification and continue to be eligible to receive investigational products if they could provide FDA with adequate assurances of future compliance with requirements applicable to the use of investigational drugs and biologics. The provisions for adequate assurances are no longer in the regulations.

-
-